Article
[Valproic acid pharmacogenetics in an individual approach to treatment of women of childbearing age with epilepsy].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova - 1 Jan 2011
Snaĭder N A, Sychev D A, Piliugina M S, Dmitrenko D V, Bochanova E N, Shapovalova E A
Abstract excerpt
A clinical case of the development of undesirable pharmacological phenomena in a woman of childbearing age with epilepsy is described. The development of undesirable pharmacological phenomena at reception of average therapeutic doses of valproic acid has been caused by the primary (idiopathic) and secondary (valproate-induced) infringement of a folic cycle against a combination of CYP2C9*3 gene polymorphism and a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.